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Abstract
Background: There is controversy about the effect of the timing of intraperitoneal administration
of chemotherapeutic agents on the healing of intestinal anastomosis. We have investigated the
effect on intestinal wound healing of mitomycin-C administered at different times post-operatively.
Methods:  Eighty-four Wistar-Albino female rats underwent ileal resection and end-to-end
anastomosis. The rats were randomly selected for intraperitoneal administration of mitomycin-C
or saline as follows: mitomycin-C group (n = 65), 2 mg/kg mitomycin-C; control group (n = 13), 10
ml saline. The former was sub-divided into 5 equal groups (A 1–5) and mitomycin-C was
administered postoperatively as follows: day 0 (A1), day 3 (A2), day 5 (A3), day 7 (A4) and day 10
(A5). All the rats were sacrificed on the 14th postoperative day and anastomotic bursting pressures
and tissue hydroxyproline levels were determined.
Results: Five of the animals died postoperatively: 2 (15.4%) in group A1, 2 (15.4%) in group A2
and 1(7.7%) in group A3. Non-lethal anastomotic leakage was observed in a further five animals: 1
in group A1, 2 in group A2, 1 in group A5 and 1 in the control group. Groups A1 and A2 had
significantly lower anastomotic bursting pressures than the other groups (P was <0.05 for each
comparison). The anastomotic bursting pressures of group A3, A4 and A5 were comparable with
those of the controls (P was >0.05 for each comparison). Tissue hydroxyproline levels in group A1
and A2 were significantly lower than in the controls (P values were <0.05 for each comparison) or
the other mitomycin-C sub-groups (P was <0.05 for each comparison).
Conclusions: Intraperitoneal chemotherapy impairs intestinal wound healing when applied before
the 5th postoperative day. Additional therapeutic approaches are needed to prevent this
potentially lethal side effect of early intraperitoneal mitomycin-C administration.
Background
Intraperitoneal (IP) administration of antineoplastic
agents has been studied in many investigative trials and
has been used in clinical practice for more than 40 years
[1]. Serosal invasion occurring in spite of curative resec-
tion is an unfavourable prognostic factor in
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gastrointestinal malignancies [2]. IP chemotherapy is now
viewed as an interesting approach to treating tumors with
peritoneal, local lymphatic or hepatic dissemination [3]
such as gastric or colon cancer. The main goal of IP admin-
istration is to increase the exposure of cancer cells in the
peritoneal cavity to the drugs with minimal potential toxic
effects on the internal organs [1,4,5]. Various chemother-
apeutic agents such as mitomycin-C (MTC), cisplatin and
5-fluorouracil, administered intraperitoneally during the
early postoperative period, have been shown to be safe
and to improve prognosis in patients with gastrointestinal
cancers [6,7].
The timing as well as the route of administration of the
chemotherapeutic agent plays a major role in determining
the response. Since drug resistance is often related to the
number of neoplastic cells present when the chemothera-
peutic treatment is initiated, early administration of the
agent in conjunction with surgery may give better results
[8]. However, the effect of chemotherapeutic agents,
delivered intravenously or intraperitoneally, on the heal-
ing of intestinal anastomosis is still controversial [9-16].
Weiber [14] investigated the influence of postoperative 5-
fluorouracil on intestinal anastomotic wound healing in
relation to timing of administration, but no other chemo-
therapeutic agents have been studied in this way. Our aim
in the present study was to investigate the effects of IP
MTC, administered at various times postoperatively, on
intestinal anastomotic wound healing. MTC has been
extensively used for treating gastric cancers.
Methods
Eighty-four Wistar-Albino female rats weighing 275 ± 25
g were acclimatized for 10 days before the study. All the
animals were in good health and were kept under the
same physical and environmental conditions. They were
fed with standard pellet diet and tap water and kept at 23
± 2°C, with a 12 h light/dark cycle, throughout the study
period. They received human care and the study protocol
complied with the institutions' guidelines. All the rats
underwent abdominal surgery under ether anesthesia.
Standardized laparotomy was performed through a 3-cm
midline incision. A 2-cm ileal segment was resected up to
10 cm proximal to the ileocecal valve. An end-to-end
anastomosis was made using interrupted 5/0 polypropyl-
ene sutures as a continuous single layer. The fascia was
closed using interrupted 3/0 polypropylene sutures. Sub-
sequently, the rats were randomly assigned to two groups:
group A, MTC group(n = 65); control (saline) group (n =
13). The MTC group was sub-divided into 5 equal (n = 13)
groups, A1-A5, and IP mitomycin-C was administered
postoperatively as follows: day 0 (A1), day 3 (A2), day 5
(A3), day 7 (A4) and day 10 (A5). Each MTC dosage was
2 mg/kg with 10 ml saline. All the rats were sacrificed with
an overdose of ether on the 14th postoperative day. Post-
mortem exploration of the abdomen to detect anasto-
motic complications was performed by an observer
blinded to the treatment arm of the study. The entire anas-
tomotic segment of ileum with 2-cm margins on either
side was removed for study.
Anastomotic bursting pressure measurement
Anastomotic bursting pressure was measured in all rats. A
catheter was inserted intraluminally into the resected seg-
ment of the ileum and secured using pursestring sutures.
A mercury manometer connected to an inflating appara-
tus was attached to the other side of the catheter and the
open end of the ileum was ligated. The resected segment
of the intestine was then totally submerged in a water pot
and gently distended with air. The bursting pressure was
recorded as mmHg at the time of appearance of the first
gas bubble.
Hydroxyproline content determination
Tissue hydroxyproline content was determined in all rats
by the Reddy method [17] and the results were recorded
as µg hydroxyproline per mg dry tissue weight.
Statistical analysis
Non-parametric continuous variables were compared by
the Kruskal-Wallis one-way analysis of variance with post-
hoc analysis using a Mann-Whitney U test. Parametric var-
iables were compared using one-way analysis of variance
with post-hoc analysis using the Tukey test. Data are pre-
sented as medians and ranges for nonparametric variables
and means ± SD for parametric variables. Differences were
regarded as significant at p < 0.05 for parametric and 0.05/
6 for nonparametric analyses.
Results
Postoperative mortality was observed in five animals: 2
(15.4%) in group A1, 2 (15.4%) in group A2 and 1 (7.7%)
in group A3. The deaths in group A1 occurred on the 1st
postoperative day; the other deaths occurred before
administration of MTC at the 2nd postoperative day. Mac-
roscopic examination during post-mortem laparotomy
showed anastomotic leakage communicating with
abdominal abscesses in all deaths. Because the deaths in
group A2 an A3 occurred before MTC administration and
those in group A1 occurred earlier, the anastomotic leak-
age was attributed to operative complication and the dead
rats were excluded from the study. No mortality occurred
in any of the remaining animals before the completion of
the study. During post-mortem abdominal explorations
at the end of the study, non-lethal anastomotic leakage
was observed in 5 animals: 1 in group A1, 2 in group A2,
1 in group A5 and 1 in the control group.BMC Cancer 2005, 5:31 http://www.biomedcentral.com/1471-2407/5/31
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Anastomotic bursting pressure
Anastomotic bursting pressures (mmHg) were 86 (0–
102), 96 (0–116), 149.5 (116–196), 175 (108–241), 193
(0–243) and 198 (0–231) in groups A1, A2, A3, A4, A5
and control, respectively (Fig. 1). The values in groups A1
and A2 were significantly lower than in groups A3, A4, A5
and control (P values were <0.05 for all these compari-
sons). There was no statistically significant difference
between groups A1 and A2 (p > 0.05). The anastomotic
bursting pressures in groups A3, A4 and A5 were not sig-
nificantly different from those in the control group (P val-
ues were >0.05/6 for these comparisons).
Tissue hydroxyproline content
The mean tissue hydroxyproline contents (µg/mg) of
groups A1, A2, A3, A4, A5 and control were 6.54 ± 1.9,
8.14 ± 2.3, 14.77 ± 3.4, 14.80 ± 4.3, 17.01 ± 3.9 and 18.28
± 4.3, respectively (Fig. 2). The values for groups A3, A4
and A5 were comparable with the controls (P values were
>0.05 for these comparisons). The tissue hydroxyproline
levels of groups A1 and A2 were significantly lower than
the controls or the other MTC sub-groups (P values were
<0.05 for these comparisons).
Discussion
Recurrence and IP dissemination of gastrointestinal can-
cers is common despite curative resection, particularly
when the serosa has been infiltrated [2]. It has been sug-
gested that IP administration of anticancer agents before
closure of the laparotomy, and during the first few post-
operative days, may prevent the dissemination of cancer
cells [18-20]. A potential criticism of delayed postopera-
tive IP administration is inhomogeneous drug distribu-
tion caused by early postoperative adhesions [21].
Entrapment of the tumor cells by fibrin in the dissected
areas decreases their exposure to the chemotherapeutic
agents [22,23]. Thus, the use of IP chemotherapy at the
time of surgery provides better drug distribution without
the risk of interference from postoperative adhesions [21].
However, although the administration of chemothera-
peutic agents in the immediate postoperative period may
decrease the local cancer recurrence rate, this must be
weighed against the possible impairment of wound heal-
ing [12,24,25].
In the present study, the animals that received IP MTC
perioperatively and on the 3rd potoperative day had sig-
nificantly lower mean tissue hydroxyproline contents and
anastomotic bursting pressures than the controls. No dif-
ference was observed between the controls and the other
MTC sub-groups. Collagen synthesis, which may be
reflected by tissue hydroxyproline content, is an essential
feature of anastomotic healing in the intestine [17,26].
We therefore measured the tissue hydroxyproline content
to determine whether MTC is detrimental to anastomotic
Anastomotic bursting pressures in mitomycin-C sub-groups  and controls Figure 1
Anastomotic bursting pressures in mitomycin-C sub-groups 
and controls. Group A1 and A2 which have received mito-
mycin-C (MTC) in preoperative (day 0) and 3rd day of post-
operative period, respectively, had significantly lower value 
than the other groups (both, p < 0.001).
Tissue hydroxyproline levels in mitomycin-C sub-groups and  controls Figure 2
Tissue hydroxyproline levels in mitomycin-C sub-groups and 
controls. Group A1 and A2 which have received mitomycin-
C in preoperative (day 0) and 3rd day of postoperative 
period, respectively, had significantly lower value than the 
other groups (both, p < 0.001).BMC Cancer 2005, 5:31 http://www.biomedcentral.com/1471-2407/5/31
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wound healing. The data showed that IP MTC adminis-
tered perioperatively or on the 3rd postoperative day was
detrimental to the healing of intestinal anastomosis, but
MTC administered on or after the 5th postoperative day
had no significant effect on the process. The effects of IP
administration of various chemotherapeutic agents on
intestinal anastomotic wound healing have been investi-
gated in many studies and the results have been conflict-
ing [12-14,16,24,27,28]; some have shown detrimental
effects [12,28]. However, the effect on wound healing of
peri- and post-operative intraperitoneal MTC administra-
tion has not been described previously.
Tissue injury initiates a cycle of inflammation, cellular
migration and replication, and connective tissue deposi-
tion and remodeling, which restores tissue integrity. Suc-
cessful wound healing depends on the formation of a
strong and stable scar. Wound strength is determined by
the amount and quality of newly-synthesized and depos-
ited collagen, and by the degradation of preformed colla-
gen [29]. Collagenase activity, which is important in
determining anastomotic integrity and suture-holding
capacity during the first few days of healing, increases sig-
nificantly after 3 days of colonic anastomosis; at this time
the suture holding capacity of the anastomosis decreases
by up to 80% [30-33]. MTC arrests the proliferation of
fibroblasts, which are responsible for several crucial
aspects of the wound-healing process outlined above [34].
Thus, IP administeration of MTC within three days of the
operation may be detrimental to intestinal anastomotic
wound healing, as shown in the present study.
Ineffective colonic wound healing can have devastating
consequences e.g. abscesses, fistula formation, or death
secondary to overwhelming sepsis. Therefore, although
early IP administration of MTC following cytoreductive
surgery is effective in preventing the dissemination of can-
cer cells, the side effects discussed here have considerable
importance and should not be overlooked.
In conclusion, certain interventions are needed to avoid
the potentially lethal side effects of chemotherapy on
intestinal wound healing in subjects receiving early IP
administration. Additional therapeutic approaches such
as anti-inflammatory or fibrinolytic agents should be
introduced to reduce adhesion formation, and thus pre-
clude inhomogeneous drug distribution, in patients for
whom IP administration has been postponed beyond the
early postoperative period to avoid the undesirable side
effects.
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